Oak Associates Ltd. OH Lowers Position in Intuitive Surgical, Inc. $ISRG

Oak Associates Ltd. OH lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.7% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,405 shares of the medical equipment provider’s stock after selling 1,618 shares during the quarter. Oak Associates Ltd. OH’s holdings in Intuitive Surgical were worth $4,658,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Truvestments Capital LLC raised its stake in Intuitive Surgical by 19.1% during the first quarter. Truvestments Capital LLC now owns 2,200 shares of the medical equipment provider’s stock valued at $1,090,000 after purchasing an additional 353 shares in the last quarter. Silvant Capital Management LLC raised its stake in Intuitive Surgical by 0.3% during the first quarter. Silvant Capital Management LLC now owns 86,287 shares of the medical equipment provider’s stock valued at $42,735,000 after purchasing an additional 252 shares in the last quarter. CreativeOne Wealth LLC raised its stake in Intuitive Surgical by 9.7% during the first quarter. CreativeOne Wealth LLC now owns 5,472 shares of the medical equipment provider’s stock valued at $2,710,000 after purchasing an additional 486 shares in the last quarter. Ieq Capital LLC raised its stake in Intuitive Surgical by 25.2% during the first quarter. Ieq Capital LLC now owns 27,325 shares of the medical equipment provider’s stock valued at $13,533,000 after purchasing an additional 5,498 shares in the last quarter. Finally, J. Stern & Co. LLP purchased a new stake in Intuitive Surgical during the first quarter valued at $2,363,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.7%

NASDAQ ISRG opened at $471.15 on Thursday. The company’s 50-day moving average price is $501.89 and its 200-day moving average price is $519.66. The stock has a market cap of $168.90 billion, a PE ratio of 65.71, a PEG ratio of 4.97 and a beta of 1.59. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.78 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. BTIG Research boosted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Citigroup reiterated a “buy” rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $595.95.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,839 shares of company stock worth $7,896,972. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.